Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Daiichi Sankyo UK Limited
Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 09/01/2012
SPC Olmetec Plus 40 mg/12.5 mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 5.2 - Pharmacokinetic Properties
Date of revision of text on the SPC:   25-Nov-2011
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company
SmPC modifications:
various amendments to sections 4.1, 4.2, 4.7, 4.8, 5.1, 5.2.
Updated on 29/03/2010 and displayed until 09/01/2012
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company
None provided

Active Ingredients/Generics

 
  hydrochlorothiazide
  olmesartan medoxomil